| Specialty Retail Industry | Consumer Discretionary Sector | Joseph K. Pagano CEO | OTC PINK Exchange | 817305105 CUSIP |
| US Country | 1 Employees | - Last Dividend | - Last Split | - IPO Date |
SentiSearch, Inc. is a company in its development stage, focusing on the cutting-edge field of insect chemosensation and olfaction. With a foundation date in the year 2000 and headquartered in New York, New York, the company has carved a niche for itself by acquiring a license that grants it the comprehensive ability to develop, manufacture, import, use, sell, distribute, rent, or lease products and services within this specialized biotechnology domain. In addition to its operational license, SentiSearch boasts a portfolio of patent applications related to nucleic acids and proteins associated with insect or odorant receptor genes, underscoring its commitment to innovation and scientific advancement in understanding and harnessing the chemistry and functionality of olfaction and chemosensation in insects.
SentiSearch is poised to harness its proprietary technology for the development and manufacturing of novel products that leverage the science of insect chemosensation and olfaction. These products have potential applications in various sectors including agriculture, where they could be used for pest control or pollination enhancement, and in health, for the development of new diagnostic tools.
The licensing agreement held by SentiSearch permits the company to import, sell, and distribute its innovative products and services globally. This capability allows the company to reach a wide market, providing cutting-edge solutions to modern challenges in pest management, agriculture productivity, and even possibly medical diagnostics through the unique perspective of insect olfaction.
SentiSearch is not only involved in the practical applications of insect chemosensation but also actively engages in the intellectual property domain by holding patent applications related to nucleic acids and proteins of insect or odorant receptor genes. These patents, once granted, could serve as a solid foundation for future research, development, and commercialization of olfaction-based technologies and innovations.